See more : Tongdao Liepin Group (TGDLF) Income Statement Analysis – Financial Results
Complete financial analysis of Parnax Lab Limited (PARNAXLAB.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Parnax Lab Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Tejnaksh Healthcare Limited (TEJNAKSH.BO) Income Statement Analysis – Financial Results
- Lux Amber, Corp. (LXAM) Income Statement Analysis – Financial Results
- FP Partner Inc. (7388.T) Income Statement Analysis – Financial Results
- Spring Valley Acquisition Corp. II (SVIIR) Income Statement Analysis – Financial Results
- Storytel AB (publ) (STRYF) Income Statement Analysis – Financial Results
Parnax Lab Limited (PARNAXLAB.BO)
About Parnax Lab Limited
Parnax Lab Ltd. engages in manufacturing and trading of pharmaceuticals and medicinal products. It offers liquid products, ointments, gels, creams, tablets and capsules. The company was founded on August 3, 1982 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.89B | 1.68B | 1.63B | 900.60M | 953.15M | 1.09B | 1.05B | 948.10M | 711.82M | 1.03B | 685.74M | 558.21M | 930.64M | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.64B | 1.16B | 1.15B | 605.08M | 665.39M | 709.13M | 722.38M | 677.48M | 491.81M | 779.52M | 491.47M | 395.82M | 830.92M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 247.44M | 512.70M | 480.15M | 295.52M | 287.76M | 378.67M | 332.60M | 270.62M | 220.01M | 247.94M | 194.26M | 162.39M | 99.72M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 13.11% | 30.59% | 29.45% | 32.81% | 30.19% | 34.81% | 31.53% | 28.54% | 30.91% | 24.13% | 28.33% | 29.09% | 10.72% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 5.83M | 2.06M | 2.79M | 448.35K | 4.18M | 9.21M | 304.67K | 452.58K | 3.72M | 0.00 | 221.34K | 510.23K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 48.27M | 45.56M | 41.55M | 36.32M | 36.09M | 36.41M | 29.45M | 32.14M | 17.57M | 3.76M | 24.84M | 15.97M | 15.61M | 170.91K | 174.93K | 50.24K | 0.00 |
| Selling & Marketing | 22.67M | 24.04M | 22.24M | 11.84M | 19.41M | 77.07M | 56.78M | 12.50M | 2.47M | 14.92M | 17.87M | 14.64M | 24.49M | 39.38K | 0.00 | 0.00 | 0.00 |
| SG&A | 70.94M | 69.60M | 63.79M | 48.16M | 55.50M | 113.48M | 86.22M | 44.64M | 20.04M | 18.68M | 42.70M | 30.61M | 40.10M | 210.28K | 174.93K | 50.24K | 0.00 |
| Other Expenses | 879.00K | 1.51M | 812.60K | 464.43K | 1.23M | 7.15M | 4.29M | 3.03M | 0.00 | 0.00 | 0.00 | 0.00 | 180.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 80.59M | 345.20M | 308.02M | 245.66M | 265.72M | 304.62M | 248.36M | 176.15M | 145.44M | 148.97M | 125.30M | 97.93M | 109.39M | 563.52K | 243.02K | 195.14K | 106.00K |
| Cost & Expenses | 1.72B | 1.51B | 1.46B | 850.74M | 931.11M | 1.01B | 970.74M | 853.64M | 637.26M | 928.49M | 616.77M | 493.74M | 940.31M | 563.52K | 243.02K | 195.14K | 106.00K |
| Interest Income | 3.37M | 2.35M | 1.62M | 862.41K | 830.43K | 765.36K | 1.49M | 552.94K | 471.41K | 474.50K | 235.89K | 140.98K | 279.22K | 0.00 | 42.65K | 0.00 | 0.00 |
| Interest Expense | 52.62M | 48.97M | 51.69M | 49.82M | 44.53M | 36.10M | 41.58M | 47.63M | 41.49M | 42.66M | 31.56M | 38.20M | 42.54M | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 69.64M | 65.29M | 58.66M | 51.60M | 44.59M | 38.24M | 37.40M | 37.52M | 28.95M | 29.93M | 21.03M | 19.32M | 18.98M | 28.00K | -42.65K | 0.00 | 0.00 |
| EBITDA | 243.60M | 237.60M | 233.60M | 100.58M | 70.94M | 123.31M | 109.20M | 132.26M | 103.36M | 125.73M | 93.10M | 83.78M | 9.32M | -549.52K | -243.02K | -195.14K | -106.00K |
| EBITDA Ratio | 12.91% | 14.31% | 14.32% | 11.25% | 7.29% | 11.15% | 11.83% | 14.12% | 14.81% | 12.67% | 12.98% | 15.01% | 1.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 166.84M | 166.81M | 176.31M | 49.75M | 23.31M | 69.30M | 87.43M | 46.09M | 34.82M | 54.41M | 34.08M | 26.41M | -51.64M | -577.52K | -200.37K | -195.14K | -106.00K |
| Operating Income Ratio | 8.84% | 9.95% | 10.81% | 5.52% | 2.45% | 6.37% | 8.29% | 4.86% | 4.89% | 5.30% | 4.97% | 4.73% | -5.55% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -46.35M | -44.01M | -53.66M | -50.58M | -41.71M | -27.85M | -54.02M | -281.45M | -200.36M | -206.22M | -51.87M | -37.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 120.50M | 122.80M | 122.64M | -837.49K | -19.67M | 46.20M | 30.22M | 47.11M | 34.82M | 54.41M | 34.08M | 26.41M | -51.64M | -577.52K | -200.37K | -195.14K | -106.00K |
| Income Before Tax Ratio | 6.39% | 7.33% | 7.52% | -0.09% | -2.06% | 4.25% | 2.86% | 4.97% | 4.89% | 5.30% | 4.97% | 4.73% | -5.55% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 24.25M | 36.47M | 40.06M | 2.79M | 9.49M | 13.15M | 19.66M | 10.19M | 9.74M | 11.84M | 9.14M | 9.31M | -23.68M | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 96.09M | 86.18M | 82.43M | -3.64M | -29.14M | 32.99M | 10.54M | 36.84M | 25.08M | 42.57M | 24.94M | 17.10M | -27.96M | -577.52K | -200.37K | -195.14K | -106.00K |
| Net Income Ratio | 5.09% | 5.14% | 5.06% | -0.40% | -3.06% | 3.03% | 1.00% | 3.89% | 3.52% | 4.14% | 3.64% | 3.06% | -3.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 8.37 | 7.79 | 9.68 | -0.43 | -3.43 | 3.88 | 1.24 | 4.33 | 2.95 | 5.01 | 2.93 | 2.01 | -3.27 | -0.18 | -0.50 | -0.49 | -0.27 |
| EPS Diluted | 8.37 | 7.79 | 9.68 | -0.43 | -3.43 | 3.88 | 1.24 | 4.33 | 2.95 | 5.01 | 2.93 | 2.01 | -3.27 | -0.18 | -0.50 | -0.49 | -0.27 |
| Weighted Avg Shares Out | 11.49M | 11.07M | 8.51M | 8.50M | 8.50M | 8.50M | 8.50M | 8.50M | 8.50M | 8.50M | 8.50M | 8.50M | 8.54M | 3.15M | 400.00K | 400.00K | 392.59K |
| Weighted Avg Shares Out (Dil) | 11.49M | 11.07M | 8.51M | 8.50M | 8.50M | 8.50M | 8.50M | 8.50M | 8.50M | 8.50M | 8.50M | 8.50M | 8.54M | 3.15M | 400.00K | 400.00K | 392.59K |
No news found for: PARNAXLAB.BO
Source: https://incomestatements.info
Category: Stock Reports